BlueStone Venture Partners is a venture capital firm that teams with inspired entrepreneurs to develop their visions to build industry-leading companies. BlueStone provides strategic capital and support to early-stage life science companies residing in, what we call the “NATO" states (New Mexico, Arizona, Texas & Oklahoma). BlueStone’s focus is in medical devices, health IT, advanced materials and molecular diagnostics. Companies in these states have historically been overlooked by many of the legacy venture capital funds despite the presence of strong research institutions, best-in-class technology, and talented leadership teams. BlueStone has a wide and deep network in the region enabling access to unique and highly attractive deals. BlueStone primarily invests in Series A and Series B equity rounds. As such, we see an opportunity to leverage our experience, invest in outstanding companies with attractive valuations, and drive superior returns for our Limited Partners.